Medicine and Dentistry
Pulmonary Hypertension
100%
Systemic Scleroderma
19%
Pulmonary Vascular Disease
14%
Scleroderma
10%
Hemodynamic
10%
Right Ventricular Function
10%
Disease
10%
Hypoxia
9%
Right Ventricle
8%
Cardiac Magnetic Resonance Imaging
7%
Cardiac Catheterization
7%
Endothelial Cell
6%
Lung Vascular Resistance
6%
Lung Artery Pressure
6%
Heart Right Ventricle Function
6%
Polycyclic Aromatic Hydrocarbon
5%
Phenomics
5%
Biological Marker
5%
Echocardiography
5%
Pulmonary Artery
5%
Keyphrases
Pulmonary Arterial Hypertension
60%
Pulmonary Hypertension
34%
Systemic Sclerosis
17%
Right Ventricular Function
13%
Right Ventricular
9%
Pulmonary Vascular Disease
9%
Xanthine Oxidase
8%
Scleroderma
8%
Right Ventricle
7%
Hypoxia
7%
Pulmonary Vascular
6%
Systemic Sclerosis-associated Pulmonary Arterial Hypertension
6%
Connective Tissue Disease
5%
Lung
5%
Hypertension Patients
5%
Endothelial Cells
5%
Pulmonary Artery Smooth muscle Cells (PASMCs)
5%
Pulmonary Vascular Resistance
5%
6-minute Walk Distance (6MWD)
5%
Right Heart Catheterization
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
74%
Systemic Sclerosis
19%
Hypoxia
14%
Scleroderma
13%
Xanthine Oxidase
10%
Disease
10%
Xanthine Dehydrogenase
6%
Pulmonary Vascular Disease
6%
Polycyclic Aromatic Hydrocarbon
6%
Connective Tissue Disease
5%
Mouse
5%
